ArticlePLoS neglected tropical diseases2025
Into the spotlight: A spatial study of potentially underreported leptospirosis among dengue-negative patients in São Paulo city, Brazil.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- An integrated case-based leptospirosis surveillance dataset with environmental context from a tropical coastal city in Indonesia, 2018-2023.Data in brief · 2026Article
- Neuroimmune cross-talk inFrontiers in immunology · 2026Review
- Leptospirosis and Respiratory Syncytial Virus (RSV) Co-infection: Diagnostic and Management Challenges.Cureus · 2025Article
- Re-emergence of Oropouche virus as a novel global threat.Current research in microbial sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Leptospirosis and dengue share similar unspecific symptoms, complicating differential diagnosis in endemic regions. This overlap is further exacerbated by the often-underrecognized nature of leptospirosis, resulting in low clinical suspicion among healthcare providers. Understanding the scale of underdiagnosed leptospirosis cases, particularly among dengue-negative patients, is critical for improving public health responses. This cross-sectional study analyzed data from 6,936 febrile patients who tested negative for dengue at public health services across São Paulo city. Serum samples from these patients were subsequently tested for anti-Leptospira IgM antibodies. Spatial analysis was conducted to identify areas at increased risk of underdiagnosed leptospirosis, and these findings were compared to cases reported in the Brazilian's Information System for Notifiable Diseases from 2009 to 2019. Our results revealed that, from the 6,936 patients tested, 786 (11.3%) were seroreactive for leptospirosis, with a higher prevalence among women (55.7%; p=0.003). Spatial analysis identified 18 high-risk clusters for potentially unrecognized leptospirosis, predominantly in peripheral regions with socioeconomic vulnerabilities. Notably, two significant high-risk areas were located in the North (RR=2.13) and South (RR=2.69) regions of the city. These findings underscore the urgent need for targeted public health interventions to improve disease surveillance and diagnostic capacity, particularly in the high-risk areas identified. Addressing underrecognition of leptospirosis is essential for reducing morbidity and mortality associated with the disease. Future research should expand on this work by integrating broader temporal, environmental, and socioeconomic data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.